MARKET NEWS

Ajinomoto Bio-Pharma Services & DNDi Partner to Develop Critical Immunomodulator for Cutaneous Leishmaniasis Therapeutic
Veru Completes Enrollment of Phase 2 Clinical Trial of Novel Oral Drug
Mereo BioPharma Receives FDA Rare Pediatric Disease Designation
FSD Pharma Begins Phase 2 Clinical Trial to Evaluate FSD201 for the Treatment of Hospitalized COVID-19 Patients
Celyad Oncology Announces Clinical Trial Collaboration With MSD
Catalent Acquires New Biologics Facility to Create North American Clinical Manufacturing Center of Excellence

  FEATURED EDITORIAL

  COMPANY PROFILE

August Bioservices today is a team of highly experienced scientists and professionals, providing comprehensive services to advance drug discovery, pharmaceutical development, and clinical manufacturing for the pharmaceutical and biotechnology industries. From dynamic testing capabilities for small and large molecules to clinical manufacturing for aseptic vial filling, creams and ointments, August Bioservices is uniquely positioned to support individual projects, or to serve as an extension of its customers’ research and development teams. Click here for more.

  EXCLUSIVE ONLINE CONTENT

FORMULATION FORUM - Parenteral Sustained Delivery of ASD-005 Liposomal Formulation: A Case Study in Applications of Lipid-Based Nanoparticle Carriers

Jim Huang, PhD, presents an investigation aimed at studying the administration of a liposomal form of a third-generation β-blocker, ASD-005, by injectable route of administration to efficiently manage emergency hypertension and congestive heart failure.

Mott's Controlled Release Drug Diffusion Studies Reduce In Vitro Test Time by Over 90% & Narrow Scope of Animal Trials

Mott's Controlled Release Drug Diffusion Studies Reduce In Vitro Test Time by Over 90% & Narrow Scope of Animal Trials

Device diffusion testing is a critical step that can delay the time for an implantable drug delivery device to get through clinical trials, regulatory hurdles and ultimately, to market. Mott conducts controlled release studies for….

Stevanato Group Launches US Technology Excellence Center in Boston

Stevanato Group Launches US Technology Excellence Center in Boston

Italian-based Stevanato Group, a leading producer of pharmaceutical glass containers and provider of integrated capabilities for drug delivery systems, has officially inaugurated its….

Gerresheimer Enters  Development & Production Agreement With Boehringer Ingelheim

Gerresheimer Enters  Development & Production Agreement With Boehringer Ingelheim

Gerresheimer has recently been commissioned by Boehringer Ingelheim with the development and large series production of the housing module for the new generation of….

Orgenesis Announces Agreement to Acquire Koligo Therapeutics

Orgenesis Announces Agreement to Acquire Koligo Therapeutics

Orgenesis Inc. and Koligo Therapeutics, Inc. recently announced the two companies have entered into a definitive merger agreement, subject to final closing conditions, with expected completion….

Schott AG & Credence MedSystems Form Strategic Collaboration Agreement

Schott AG & Credence MedSystems Form Strategic Collaboration Agreement

Credence MedSystems and SCHOTT AG have recently formed a collaboration for the application of Credence Companion technology with SCHOTT’s prefillable syriQ glass and SCHOTT TOPPAC polymer syringe systems…..

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

October 14 – Bioavailability
October 21 – Capsules